Study of Neurovascular Device Market by Aneurysm Coiling & Embolization Devices from 2024 to 2034

<p>In the latest report by Future Market Insights, the lead research consultant estimates the global <strong>Neurovascular Device market</strong> value to reach US$ 3.0 billion in 2024.</p><table><tbody><tr><th scope='row'>Attributes</th><td>Key Insights</td></tr><tr><th scope='row'>Neurovascular Device Market Estimated Size in 2024</th><td>US$ 3.0 billion</td></tr><tr><th scope='row'>Projected Market Value in 2034</th><td>US$ 3.9 billion</td></tr><tr><th scope='row'>Value-based CAGR from 2024 to 2034</th><td>2.7%</td></tr></tbody></table><p>Country-wise Insights</p><table><tbody><tr><th scope='row'>Countries</th><td>Forecast CAGRs from 2024 to 2034</td></tr><tr><th scope='row'>The United States</th><td>1.4%</td></tr><tr><th scope='row'>Germany</th><td>2.2%</td></tr><tr><th scope='row'>France</th><td>3.3%</td></tr><tr><th scope='row'>Thailand</th><td>3.4%</td></tr><tr><th scope='row'>India</th><td>5.5%</td></tr></tbody></table><p>Category-wise Insights</p><table><tbody><tr><th scope='row'>Category</th><td>Shares in 2024</td></tr><tr><th scope='row'>Aneurysm Coiling and Embolization</th><td>31.7%</td></tr><tr><th scope='row'>Cerebral Aneuryms</th><td>26.9%</td></tr></tbody></table><p>Report Scope</p><table><tbody><tr><th scope='row'>Attribute</th><td>Details</td></tr><tr><th scope='row'>Estimated Market Size in 2024</th><td>US$ 3.0 billion</td></tr><tr><th scope='row'>Projected Market Valuation in 2034</th><td>US$ 3.9 billion</td></tr><tr><th scope='row'>Value-based CAGR 2024 to 2034</th><td>2.7%</td></tr><tr><th scope='row'>Forecast Period</th><td>2024 to 2034</td></tr><tr><th scope='row'>Historical Data Available for</th><td>2019 to 2023</td></tr><tr><th scope='row'>Market Analysis</th><td>Value in US$ Billion</td></tr><tr><th scope='row'>Key Regions Covered</th><td><ul><li>North America</li><li>Latin America</li><li>Western Europe</li><li>Eastern Europe</li><li>South Asia and Pacific</li><li>East Asia</li><li>The Middle East &amp; Africa</li></ul></td></tr><tr><th scope='row'>Key Market Segments Covered</th><td><ul><li>Product</li><li>Disease Pathology</li><li>End User</li><li>Region</li></ul></td></tr><tr><th scope='row'>Key Countries Profiled</th><td><ul><li>The United States</li><li>Canada</li><li>Brazil</li><li>Mexico</li><li>Germany</li><li>France</li><li>France</li><li>Spain</li><li>Italy</li><li>Russia</li><li>Poland</li><li>Czech Republic</li><li>Romania</li><li>India</li><li>Bangladesh</li><li>Australia</li><li>New Zealand</li><li>China</li><li>Japan</li><li>South Korea</li><li>GCC countries</li><li>South Africa</li><li>Israel</li></ul></td></tr><tr><th scope='row'>Key Companies Profiled</th><td><ul><li>Medtronic</li><li>Penumbra, Inc.</li><li>Stryker</li><li>Johnson and Johnson Services, Inc.</li><li>MicroPort Scientific Corporation</li><li>Acandis GmbH</li><li>MicroVention, Inc.</li><li>NeuroVasc Technologies, Inc.</li><li>Asahi Intecc USA, Inc.</li><li>Perflow Medical Ltd.</li></ul></td></tr></tbody></table>

<p>在最新发布的Future Market Insights报告中，首席研究顾问预测，全球神经血管设备市场规模预计将在2024年达到30亿美元。</p><table><tbody><tr><th scope='row'>属性</th><td>核心洞察</td></tr><tr><th scope='row'>2024年神经血管设备市场规模预测</th><td>30亿美元</td></tr><tr><th scope='row'>2034年市场价值预测</th><td>39亿美元</td></tr><tr><th scope='row'>2024年至2034年基于价值的复合年增长率(CAGR)</th><td>2.7%</td></tr></tbody></table><p>各国洞察</p><table><tbody><tr><th scope='row'>国家</th><td>2024年至2034年预测CAGR</td></tr><tr><th scope='row'>美国</th><td>1.4%</td></tr><tr><th scope='row'>德国</th><td>2.2%</td></tr><tr><th scope='row'>法国</th><td>3.3%</td></tr><tr><th scope='row'>泰国</th><td>3.4%</td></tr><tr><th scope='row'>印度</th><td>5.5%</td></tr></tbody></table><p>按类别洞察</p><table><tbody><tr><th scope='row'>类别</th><td>2024年市场份额</td></tr><tr><th scope='row'>动脉瘤栓塞和栓塞术</th><td>31.7%</td></tr><tr><th scope='row'>脑动脉瘤</th><td>26.9%</td></tr></tbody></table><p>报告范围</p><table><tbody><tr><th scope='row'>属性</th><td>详情</td></tr><tr><th scope='row'>2024年市场规模预测</th><td>30亿美元</td></tr><tr><th scope='row'>2034年市场价值预测</th><td>39亿美元</td></tr><tr><th scope='row'>2024年至2034年基于价值的复合年增长率(CAGR)</th><td>2.7%</td></tr><tr><th scope='row'>预测期</th><td>2024年至2034年</td></tr><tr><th scope='row'>可获取的历史数据</th><td>2019年至2023年</td></tr><tr><th scope='row'>市场分析</th><td>以美元十亿为单位的价值</td></tr><tr><th scope='row'>涵盖的主要地区</th><td><ul><li>北美</li><li>拉丁美洲</li><li>西欧</li><li>东欧</li><li>南亚及太平洋地区</li><li>东亚</li><li>中东及非洲</li></ul></td></tr><tr><th scope='row'>涵盖的主要市场细分</th><td><ul><li>产品</li><li>疾病病理</li><li>最终用户</li><li>地区</li></ul></td></tr><tr><th scope='row'>概述的主要国家</th><td><ul><li>美国</li><li>加拿大</li><li>巴西</li><li>墨西哥</li><li>德国</li><li>法国</li><li>西班牙</li><li>意大利</li><li>俄罗斯</li><li>波兰</li><li>捷克共和国</li><li>罗马尼亚</li><li>印度</li><li>孟加拉国</li><li>澳大利亚</li><li>新西兰</li><li>中国</li><li>日本</li><li>韩国</li><li>海湾合作委员会(GCC)国家</li><li>南非</li><li>以色列</li></ul></td></tr><tr><th scope='row'>概述的主要公司</th><td><ul><li>美敦力(Medtronic)</li><li>Penumbra, Inc.</li><li>Stryker</li><li>强生公司(Johnson and Johnson Services, Inc.)</li><li>微创医疗科学有限公司(MicroPort Scientific Corporation)</li><li>Acandis GmbH</li><li>MicroVention, Inc.</li><li>NeuroVasc Technologies, Inc.</li><li>旭化成美国公司(Asahi Intecc USA, Inc.)</li><li>Perflow Medical Ltd.</li></ul></td></tr></tbody></table>